Scandinavia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Scandinavia

The Scandinavia human and animal blood market contracted to $X in 2022, flattening at the previous year. The market value increased at an average annual rate of X% from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations being recorded in certain years. As a result, consumption attained the peak level of $X. From 2019 to 2022, the growth of the market failed to regain momentum.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Scandinavia

In value terms, human and animal blood production dropped slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations in certain years. The most prominent rate of growth was recorded in 2018 with an increase of X%. As a result, production reached the peak level of $X. From 2019 to 2022, production growth failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Scandinavia

In 2022, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported in Scandinavia; with a decrease of X% on 2021 figures. Over the period under review, exports saw a deep reduction. The pace of growth was the most pronounced in 2017 when exports increased by X% against the previous year. As a result, the exports reached the peak of X tons. From 2018 to 2022, the growth of the exports failed to regain momentum.

In value terms, human and animal blood exports declined markedly to $X in 2022. Overall, exports showed a mild curtailment. The most prominent rate of growth was recorded in 2017 with an increase of X%. As a result, the exports attained the peak of $X. From 2018 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

In 2022, Norway (X tons) and Finland (X tons) were the largest exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Scandinavia, together achieving X% of total exports. It was distantly followed by Sweden (X tons), achieving a X% share of total exports.

From 2012 to 2022, the biggest increases were recorded for Norway (with a CAGR of X%), while shipments for the other leaders experienced a decline in the exports figures.

In value terms, Finland ($X), Sweden ($X) and Norway ($X) appeared to be the countries with the highest levels of exports in 2022.

Norway, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other leaders experienced mixed trends in the exports figures.

Export Prices by Country

In 2022, the export price in Scandinavia amounted to $X per ton, growing by X% against the previous year. Export price indicated prominent growth from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, human and animal blood export price increased by X% against 2016 indices. The most prominent rate of growth was recorded in 2020 when the export price increased by X% against the previous year. Over the period under review, the export prices reached the maximum in 2022 and is likely to see gradual growth in years to come.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Sweden ($X per ton), while Norway ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Sweden (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Scandinavia

In 2022, human and animal blood imports in Scandinavia soared to X tons, rising by X% compared with 2021 figures. Overall, imports showed prominent growth. The growth pace was the most rapid in 2016 with an increase of X%. Over the period under review, imports reached the peak figure in 2022 and are likely to see steady growth in the immediate term.

In value terms, human and animal blood imports surged to $X in 2022. Over the period under review, imports recorded a resilient expansion. The most prominent rate of growth was recorded in 2016 when imports increased by X%. The level of import peaked in 2022 and is likely to see steady growth in the immediate term.

Imports by Country

Sweden dominates imports structure, amounting to X tons, which was near X% of total imports in 2022. It was distantly followed by Norway (X tons), mixing up a X% share of total imports. Finland (X tons) held a relatively small share of total imports.

Imports into Sweden increased at an average annual rate of X% from 2012 to 2022. At the same time, Norway (X%) displayed positive paces of growth. Moreover, Norway emerged as the fastest-growing importer imported in Scandinavia, with a CAGR of X% from 2012-2022. By contrast, Finland (X%) illustrated a downward trend over the same period. Sweden (X p.p.) significantly strengthened its position in terms of the total imports, while Finland saw its share reduced by X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Sweden ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Scandinavia, comprising X% of total imports. The second position in the ranking was taken by Norway ($X), with a X% share of total imports.

From 2012 to 2022, the average annual growth rate of value in Sweden stood at X%. In the other countries, the average annual rates were as follows: Norway (X% per year) and Finland (X% per year).

Import Prices by Country

In 2022, the import price in Scandinavia amounted to $X per ton, surging by X% against the previous year. Import price indicated a remarkable increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, human and animal blood import price increased by X% against 2014 indices. The pace of growth was the most pronounced in 2017 when the import price increased by X%. Over the period under review, import prices reached the peak figure in 2022 and is expected to retain growth in the immediate term.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Finland ($X per ton), while Norway ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Finland (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :